This page shows the latest Breast Cancer Now news and features for those working in and with pharma, biotech and healthcare.
Women in England and Wales with advanced breast cancer can now get access to two CDK 4/6 inhibitor drugs - Pfizer’s Ibrance and Novartis’Kisqali - after pricing negotiations between the ... important breakthroughs for women with advanced breast
AstraZeneca's hopes of expanding the use of its breast cancer therapy Faslodex in the UK look rocky after NICE rejected the drug in draft guidance. ... Baroness Delyth Morgan, chief executive at medical charity Breast Cancer Now, said the verdict was
Novartis claims EU approval for breast cancer drug Kisqali. Firm's CDK4/6 inhibitor can now challenge Pfizer's Ibrance in Europe. ... Novartis can now challenge Pfizer's blockbuster breast cancer drug Ibrance in Europe after gaining approval for its
their indications into other indications such as breast cancer. ... Another candidate - AbbVie's veliparib - failed two phase III trials in April (in breast and lung cancer) and now looks unlikely to challenge the leaders.
The agreement has been welcomed by charity Breast Cancer Now, which has been pushing hard for a price cut on the drug for years. ... Breast Cancer Now delivered a warning about another Roche HER2 drug - Perjeta (pertuzumab) - which it said was at risk
AstraZeneca's Lynparza was the first PARP inhibitor to reach the market for BRAC-positive ovarian cancer, and is now the first drug in its class to show effectiveness in breast ... The data were well-received at ASCO, with the organisation's president -
More from news
Approximately 2 fully matching, plus 30 partially matching documents found.
Two days after the student midwife’s tweet, UK organisation Breast Cancer Now shared its own response to the guidance, also tweeting to Pfizer and NICE and urging them to work ... Breast Cancer Now is followed by almost 40, 000, and its tweet, which it
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
We’re an independent brand and marketing agency that believes our DNA is a little different from others. * A respectful,...